UPCOMING SESSIONS
April 23 - 1 PM CST
HYMPAVZI: An innovative treatment approach for eligible patients with hemophilia A and B without inhibitors
Learn about HYMPAVZI (marstacimab-hncq) and the patient experience, with Dr. Davide Matino, MD, MSc and Peter Fischer, HYMPAVZI clinical trial patient
Speakers: Dr. Davide Matino, MD, MSc; Associate professor of medicine, McMaster University, MU Medical Center Hemophilia Clinic, and Thrombosis Clinic at the Juravinski Hospital and Peter Fischer, HYMPAVZI clinical trial patient
Learn about HYMPAVZI (marstacimab-hncq) and the patient experience, with Dr. Davide Matino, MD, MSc and Peter Fischer, HYMPAVZI clinical trial patient
Speakers: Dr. Davide Matino, MD, MSc; Associate professor of medicine, McMaster University, MU Medical Center Hemophilia Clinic, and Thrombosis Clinic at the Juravinski Hospital and Peter Fischer, HYMPAVZI clinical trial patient
This session is sponsored by Pfizer
Join us on your phone, tablet, or computer
All sessions will be presented in a live zoom meeting so you can interact with attendees, have your questions answered by experts, and have fun with our amazing prizes and giveaways.
